Impurities & Standards
From peptide impurities to oligonucleotide standards, we deliver uncompromising quality assurance backed by expert scientific guidance.
At NeoBio, we provide specialized consulting in peptide formulation development and analytical characterization. Peptide therapeutics demand more than routine analysis and require strategic study design, expert data interpretation, and regulatory‑ready documentation. Our consulting services help you navigate complexity, strengthen scientific rigor, and prepare your programs for successful regulatory submission.
We deliver high‑quality peptide and oligonucleotide impurities and standards that meet the most rigorous global benchmarks. Trusted by scientists and research institutions worldwide, our materials ensure reliability, consistency, and confidence in discovery.
NeoBio combines dependable standards with regulatory expertise — empowering innovation while ensuring compliance.
At NeoBio, we combine scientific rigor with regulatory expertise to support research teams worldwide.
Together, these strengths make NeoBio the trusted partner for advancing peptide and oligonucleotide innovation with confidence and precision.
From peptide impurities to oligonucleotide standards, we deliver uncompromising quality assurance backed by expert scientific guidance.
Strong expertise in formulation development and analytical characterization ensures robust, reliable outcomes.
Consulting tailored to FDA, EMA, and ICH expectations keeps your projects compliant and future‑ready.
We transform complex datasets into actionable insights that accelerate innovation.
Regulatory‑ready reports and dossiers communicate your results with clarity, authority, and impact.
Inspired by and collaborating with leading global innovators, we deliver high-quality peptide and oligonucleotide impurities and standards. Our commitment to excellence is matched by a personalized approach that ensures every client receives tailored support and trusted results.
At NeoBio, we aspire to be the trusted global partner for scientists, researchers, and pharmaceutical companies. We unite scientific guidance with quality assurance to deliver peptide and oligonucleotide standards that meet the highest regulatory expectations.
Our vision is to simplify complex development journeys by providing end-to-end CMC consulting, Study design, strategic support for API and drug product stability, and expert guidance in impurity identification and characterization and scientific writing.
We empower our partners with consulting in formulation process development.
We provide strategic support in contract service provider identification, request for proposal management, and tech transfer consulting.
Explore our catalog today and discover how NeoBio can support your research and development journey. Together, we can shape the future of peptide and oligonucleotide therapeutics.